Structure

Physi-Chem Properties

Molecular Weight:  316.13
Volume:  322.347
LogP:  3.766
LogD:  3.301
LogS:  -3.691
# Rotatable Bonds:  3
TPSA:  65.74
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.629
Synthetic Accessibility Score:  3.302
Fsp3:  0.444
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.654
MDCK Permeability:  2.520888483559247e-05
Pgp-inhibitor:  0.802
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.011
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.058
Plasma Protein Binding (PPB):  94.07695770263672%
Volume Distribution (VD):  0.879
Pgp-substrate:  9.139395713806152%

ADMET: Metabolism

CYP1A2-inhibitor:  0.82
CYP1A2-substrate:  0.856
CYP2C19-inhibitor:  0.667
CYP2C19-substrate:  0.301
CYP2C9-inhibitor:  0.565
CYP2C9-substrate:  0.78
CYP2D6-inhibitor:  0.256
CYP2D6-substrate:  0.301
CYP3A4-inhibitor:  0.21
CYP3A4-substrate:  0.423

ADMET: Excretion

Clearance (CL):  6.93
Half-life (T1/2):  0.306

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.98
Drug-inuced Liver Injury (DILI):  0.906
AMES Toxicity:  0.087
Rat Oral Acute Toxicity:  0.11
Maximum Recommended Daily Dose:  0.229
Skin Sensitization:  0.141
Carcinogencity:  0.894
Eye Corrosion:  0.003
Eye Irritation:  0.015
Respiratory Toxicity:  0.628

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC281241

Natural Product ID:  NPC281241
Common Name*:   [(9R)-8,8-Dimethyl-2-Oxo-9,10-Dihydropyrano[2,3-H]Chromen-9-Yl] 2-Methylpropanoate
IUPAC Name:   [(9R)-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-9-yl] 2-methylpropanoate
Synonyms:  
Standard InCHIKey:  PKHNHXIOSSYBJU-CQSZACIVSA-N
Standard InCHI:  InChI=1S/C18H20O5/c1-10(2)17(20)21-14-9-12-13(23-18(14,3)4)7-5-11-6-8-15(19)22-16(11)12/h5-8,10,14H,9H2,1-4H3/t14-/m1/s1
SMILES:  O=C(C(C)C)O[C@@H]1Cc2c(OC1(C)C)ccc1c2oc(=O)cc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449490
PubChem CID:   11823236
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives
        • [CHEMONTID:0003484] Pyranocoumarins
          • [CHEMONTID:0003485] Angular pyranocoumarins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32915 prionosciadium watsoni Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[12088423]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT886 Cell Line NIH3T3 Mus musculus Survival = 45.72 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Survival = 55.6 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Survival = 67.43 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Survival = 83.14 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Activity = 31.31 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Activity = 25.89 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Activity = 19.53 % PMID[540216]
NPT886 Cell Line NIH3T3 Mus musculus Activity = 8.13 % PMID[540216]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 23.52 % PMID[540215]
NPT965 Organism Amaranthus hypochondriacus Amaranthus hypochondriacus IC50 = 237000.0 nM PMID[540215]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli IC50 = 169000.0 nM PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 19.59 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 58.81 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 100.0 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 20.0 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 54.3 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 84.92 % PMID[540215]
NPT854 Organism Lemna paucicostata Lemna paucicostata GI = 87.38 % PMID[540215]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 100.08 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 101.3 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 110.34 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 147.43 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Survival = 44.77 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Survival = 56.11 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Survival = 66.48 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Survival = 82.32 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 28.99 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 23.78 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 18.04 % PMID[540216]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens Activity = 7.64 % PMID[540216]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC281241 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471625
1.0 High Similarity NPC86892
1.0 High Similarity NPC472424
1.0 High Similarity NPC471909
0.9922 High Similarity NPC128529
0.9922 High Similarity NPC55615
0.9922 High Similarity NPC283019
0.9922 High Similarity NPC166672
0.9922 High Similarity NPC471630
0.9922 High Similarity NPC160727
0.9922 High Similarity NPC74655
0.9922 High Similarity NPC476455
0.9922 High Similarity NPC195343
0.9922 High Similarity NPC177281
0.9922 High Similarity NPC198381
0.9922 High Similarity NPC149320
0.9922 High Similarity NPC287182
0.9922 High Similarity NPC164269
0.9922 High Similarity NPC127888
0.9922 High Similarity NPC100986
0.9922 High Similarity NPC47163
0.9922 High Similarity NPC84894
0.9922 High Similarity NPC267412
0.9922 High Similarity NPC319859
0.9922 High Similarity NPC18804
0.9922 High Similarity NPC260265
0.9844 High Similarity NPC133956
0.9844 High Similarity NPC167111
0.9844 High Similarity NPC207002
0.9844 High Similarity NPC318400
0.9844 High Similarity NPC471910
0.9844 High Similarity NPC296624
0.9624 High Similarity NPC287286
0.9621 High Similarity NPC211110
0.9615 High Similarity NPC307412
0.9615 High Similarity NPC55149
0.9549 High Similarity NPC312881
0.9538 High Similarity NPC222036
0.9538 High Similarity NPC7526
0.9478 High Similarity NPC152771
0.9478 High Similarity NPC195357
0.9474 High Similarity NPC279573
0.9462 High Similarity NPC14248
0.9398 High Similarity NPC155963
0.9398 High Similarity NPC153818
0.9398 High Similarity NPC232246
0.9394 High Similarity NPC469675
0.9338 High Similarity NPC183646
0.9338 High Similarity NPC119640
0.9328 High Similarity NPC151946
0.9323 High Similarity NPC78746
0.9323 High Similarity NPC224543
0.9323 High Similarity NPC188380
0.9323 High Similarity NPC283331
0.9308 High Similarity NPC80170
0.9297 High Similarity NPC471826
0.927 High Similarity NPC476457
0.9254 High Similarity NPC281014
0.9254 High Similarity NPC225106
0.9254 High Similarity NPC294456
0.9254 High Similarity NPC212124
0.9254 High Similarity NPC184861
0.9248 High Similarity NPC472525
0.9231 High Similarity NPC168710
0.9219 High Similarity NPC471828
0.9219 High Similarity NPC471827
0.9203 High Similarity NPC469701
0.9179 High Similarity NPC38099
0.9179 High Similarity NPC26954
0.9173 High Similarity NPC180716
0.9173 High Similarity NPC62366
0.9173 High Similarity NPC213173
0.9173 High Similarity NPC224475
0.9154 High Similarity NPC199204
0.9154 High Similarity NPC139595
0.9154 High Similarity NPC293642
0.9154 High Similarity NPC60704
0.9154 High Similarity NPC472519
0.9141 High Similarity NPC201667
0.9141 High Similarity NPC27671
0.9141 High Similarity NPC111347
0.9141 High Similarity NPC73413
0.9104 High Similarity NPC33986
0.9098 High Similarity NPC31849
0.9098 High Similarity NPC469955
0.9098 High Similarity NPC469952
0.9065 High Similarity NPC85624
0.9062 High Similarity NPC472518
0.9062 High Similarity NPC109675
0.9062 High Similarity NPC273772
0.9044 High Similarity NPC270256
0.903 High Similarity NPC98179
0.903 High Similarity NPC326600
0.903 High Similarity NPC253574
0.903 High Similarity NPC204353
0.903 High Similarity NPC50896
0.9008 High Similarity NPC185066
0.9 High Similarity NPC234109
0.9 High Similarity NPC188327
0.8993 High Similarity NPC471824
0.8992 High Similarity NPC291899
0.8984 High Similarity NPC248429
0.8984 High Similarity NPC96286
0.8947 High Similarity NPC29734
0.8936 High Similarity NPC296377
0.8936 High Similarity NPC87950
0.8936 High Similarity NPC471764
0.8915 High Similarity NPC154176
0.8915 High Similarity NPC50720
0.8915 High Similarity NPC290605
0.8915 High Similarity NPC173350
0.8881 High Similarity NPC469956
0.8881 High Similarity NPC194277
0.8881 High Similarity NPC19157
0.8873 High Similarity NPC169510
0.8872 High Similarity NPC113098
0.8865 High Similarity NPC171656
0.8865 High Similarity NPC294365
0.8864 High Similarity NPC157212
0.8837 High Similarity NPC150214
0.8837 High Similarity NPC257188
0.8837 High Similarity NPC13007
0.8832 High Similarity NPC471068
0.8832 High Similarity NPC306365
0.8832 High Similarity NPC14697
0.8832 High Similarity NPC471069
0.8828 High Similarity NPC235190
0.8828 High Similarity NPC180006
0.8828 High Similarity NPC163200
0.8815 High Similarity NPC241165
0.8815 High Similarity NPC142563
0.8815 High Similarity NPC1220
0.8815 High Similarity NPC163557
0.8815 High Similarity NPC291551
0.8815 High Similarity NPC469449
0.8815 High Similarity NPC54503
0.8815 High Similarity NPC141822
0.8815 High Similarity NPC469965
0.8815 High Similarity NPC55147
0.8815 High Similarity NPC205797
0.8806 High Similarity NPC272650
0.8806 High Similarity NPC267336
0.8788 High Similarity NPC289316
0.8777 High Similarity NPC472523
0.8769 High Similarity NPC315807
0.8768 High Similarity NPC144512
0.8768 High Similarity NPC37428
0.8768 High Similarity NPC137262
0.8768 High Similarity NPC47040
0.8768 High Similarity NPC471070
0.8768 High Similarity NPC35501
0.8768 High Similarity NPC471072
0.8768 High Similarity NPC278600
0.8768 High Similarity NPC307883
0.8768 High Similarity NPC471071
0.876 High Similarity NPC144418
0.8759 High Similarity NPC167517
0.875 High Similarity NPC309953
0.875 High Similarity NPC131950
0.875 High Similarity NPC103116
0.8741 High Similarity NPC123954
0.8731 High Similarity NPC19242
0.8712 High Similarity NPC163248
0.8696 High Similarity NPC131198
0.8686 High Similarity NPC311430
0.8686 High Similarity NPC224941
0.8676 High Similarity NPC472522
0.8676 High Similarity NPC241341
0.8676 High Similarity NPC233018
0.8676 High Similarity NPC36437
0.8672 High Similarity NPC298796
0.8672 High Similarity NPC281356
0.8662 High Similarity NPC43716
0.8662 High Similarity NPC295696
0.8662 High Similarity NPC76657
0.8662 High Similarity NPC475719
0.8662 High Similarity NPC101255
0.8647 High Similarity NPC258567
0.8647 High Similarity NPC121740
0.8647 High Similarity NPC243688
0.8647 High Similarity NPC224774
0.8643 High Similarity NPC138149
0.8643 High Similarity NPC155552
0.8636 High Similarity NPC202594
0.8636 High Similarity NPC232692
0.8626 High Similarity NPC143725
0.8623 High Similarity NPC104796
0.8623 High Similarity NPC286843
0.8621 High Similarity NPC164299
0.8613 High Similarity NPC147030
0.8603 High Similarity NPC319969
0.8603 High Similarity NPC175159
0.8603 High Similarity NPC137669
0.8594 High Similarity NPC152306
0.8594 High Similarity NPC265547
0.8594 High Similarity NPC96705
0.8593 High Similarity NPC32463
0.8592 High Similarity NPC471763
0.8582 High Similarity NPC469453
0.8582 High Similarity NPC20631

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC281241 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8815 High Similarity NPD5124 Phase 1
0.8815 High Similarity NPD5123 Clinical (unspecified phase)
0.838 Intermediate Similarity NPD1652 Phase 2
0.8195 Intermediate Similarity NPD422 Phase 1
0.8146 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8058 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8043 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.8042 Intermediate Similarity NPD2796 Approved
0.7987 Intermediate Similarity NPD7075 Discontinued
0.7972 Intermediate Similarity NPD3748 Approved
0.7961 Intermediate Similarity NPD6801 Discontinued
0.7945 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD1653 Approved
0.7929 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD1296 Phase 2
0.7914 Intermediate Similarity NPD4908 Phase 1
0.7867 Intermediate Similarity NPD920 Approved
0.7829 Intermediate Similarity NPD4380 Phase 2
0.7808 Intermediate Similarity NPD2424 Discontinued
0.78 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7794 Intermediate Similarity NPD1610 Phase 2
0.7792 Intermediate Similarity NPD7819 Suspended
0.7785 Intermediate Similarity NPD6799 Approved
0.7778 Intermediate Similarity NPD7097 Phase 1
0.7778 Intermediate Similarity NPD7411 Suspended
0.7778 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD5494 Approved
0.7764 Intermediate Similarity NPD5844 Phase 1
0.7755 Intermediate Similarity NPD1243 Approved
0.7734 Intermediate Similarity NPD1358 Approved
0.7733 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.771 Intermediate Similarity NPD5535 Approved
0.7704 Intermediate Similarity NPD5691 Approved
0.7703 Intermediate Similarity NPD3750 Approved
0.7698 Intermediate Similarity NPD3266 Approved
0.7698 Intermediate Similarity NPD2797 Approved
0.7698 Intermediate Similarity NPD3267 Approved
0.7692 Intermediate Similarity NPD1613 Approved
0.7692 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD3134 Approved
0.7647 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD5403 Approved
0.763 Intermediate Similarity NPD1548 Phase 1
0.7628 Intermediate Similarity NPD3817 Phase 2
0.7616 Intermediate Similarity NPD5401 Approved
0.7597 Intermediate Similarity NPD6599 Discontinued
0.7595 Intermediate Similarity NPD919 Approved
0.758 Intermediate Similarity NPD7768 Phase 2
0.7578 Intermediate Similarity NPD9697 Approved
0.7569 Intermediate Similarity NPD4307 Phase 2
0.7569 Intermediate Similarity NPD4060 Phase 1
0.7568 Intermediate Similarity NPD1549 Phase 2
0.7554 Intermediate Similarity NPD4749 Approved
0.7552 Intermediate Similarity NPD6798 Discontinued
0.7552 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD3268 Approved
0.7535 Intermediate Similarity NPD6832 Phase 2
0.7535 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD6355 Discontinued
0.7516 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5402 Approved
0.75 Intermediate Similarity NPD3225 Approved
0.75 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8651 Approved
0.75 Intermediate Similarity NPD1934 Approved
0.7483 Intermediate Similarity NPD4625 Phase 3
0.7483 Intermediate Similarity NPD7033 Discontinued
0.747 Intermediate Similarity NPD7549 Discontinued
0.7467 Intermediate Similarity NPD4628 Phase 3
0.7465 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD3496 Discontinued
0.7439 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1091 Approved
0.741 Intermediate Similarity NPD6559 Discontinued
0.7397 Intermediate Similarity NPD4340 Discontinued
0.7391 Intermediate Similarity NPD4626 Approved
0.7383 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD6004 Phase 3
0.7383 Intermediate Similarity NPD6005 Phase 3
0.7383 Intermediate Similarity NPD6002 Phase 3
0.7383 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD6233 Phase 2
0.7365 Intermediate Similarity NPD2799 Discontinued
0.7365 Intermediate Similarity NPD4308 Phase 3
0.7365 Intermediate Similarity NPD1510 Phase 2
0.7362 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD3027 Phase 3
0.7343 Intermediate Similarity NPD2861 Phase 2
0.7342 Intermediate Similarity NPD8455 Phase 2
0.7333 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7837 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD1551 Phase 2
0.7315 Intermediate Similarity NPD2935 Discontinued
0.731 Intermediate Similarity NPD2313 Discontinued
0.7297 Intermediate Similarity NPD4536 Approved
0.7297 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD4538 Approved
0.7296 Intermediate Similarity NPD2415 Discontinued
0.729 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD1611 Approved
0.7285 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD1933 Approved
0.7279 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD37 Approved
0.7273 Intermediate Similarity NPD2684 Approved
0.7273 Intermediate Similarity NPD1019 Discontinued
0.7267 Intermediate Similarity NPD5763 Approved
0.7267 Intermediate Similarity NPD5762 Approved
0.7259 Intermediate Similarity NPD1241 Discontinued
0.7255 Intermediate Similarity NPD5058 Phase 3
0.7255 Intermediate Similarity NPD6667 Approved
0.7255 Intermediate Similarity NPD6666 Approved
0.725 Intermediate Similarity NPD4966 Approved
0.725 Intermediate Similarity NPD4967 Phase 2
0.725 Intermediate Similarity NPD4965 Approved
0.7241 Intermediate Similarity NPD7095 Approved
0.7239 Intermediate Similarity NPD7229 Phase 3
0.7237 Intermediate Similarity NPD7466 Approved
0.7237 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD2801 Approved
0.7226 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD4140 Approved
0.7205 Intermediate Similarity NPD3749 Approved
0.72 Intermediate Similarity NPD6100 Approved
0.72 Intermediate Similarity NPD2438 Suspended
0.72 Intermediate Similarity NPD6099 Approved
0.7197 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD5585 Approved
0.7192 Intermediate Similarity NPD7985 Registered
0.7188 Intermediate Similarity NPD5353 Approved
0.7185 Intermediate Similarity NPD7843 Approved
0.7178 Intermediate Similarity NPD1247 Approved
0.7178 Intermediate Similarity NPD7199 Phase 2
0.7178 Intermediate Similarity NPD8127 Discontinued
0.7174 Intermediate Similarity NPD7644 Approved
0.7169 Intermediate Similarity NPD3818 Discontinued
0.7163 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD2532 Approved
0.7161 Intermediate Similarity NPD2534 Approved
0.7161 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD2533 Approved
0.716 Intermediate Similarity NPD6234 Discontinued
0.7153 Intermediate Similarity NPD7157 Approved
0.7152 Intermediate Similarity NPD6166 Phase 2
0.7152 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD17 Approved
0.7143 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1778 Approved
0.7134 Intermediate Similarity NPD6232 Discontinued
0.7133 Intermediate Similarity NPD5588 Approved
0.7133 Intermediate Similarity NPD5960 Phase 3
0.7126 Intermediate Similarity NPD7054 Approved
0.7125 Intermediate Similarity NPD1465 Phase 2
0.7113 Intermediate Similarity NPD9717 Approved
0.7108 Intermediate Similarity NPD7473 Discontinued
0.7103 Intermediate Similarity NPD3018 Phase 2
0.7097 Intermediate Similarity NPD7212 Phase 2
0.7097 Intermediate Similarity NPD7213 Phase 3
0.7097 Intermediate Similarity NPD1511 Approved
0.7095 Intermediate Similarity NPD1240 Approved
0.7095 Intermediate Similarity NPD2979 Phase 3
0.7091 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6032 Approved
0.7083 Intermediate Similarity NPD7472 Approved
0.7083 Intermediate Similarity NPD7074 Phase 3
0.7081 Intermediate Similarity NPD4288 Approved
0.7078 Intermediate Similarity NPD3887 Approved
0.7073 Intermediate Similarity NPD6959 Discontinued
0.7068 Intermediate Similarity NPD290 Approved
0.7067 Intermediate Similarity NPD2200 Suspended
0.7063 Intermediate Similarity NPD4433 Discontinued
0.7059 Intermediate Similarity NPD6674 Discontinued
0.7059 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD7447 Phase 1
0.705 Intermediate Similarity NPD5536 Phase 2
0.7048 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD447 Suspended
0.7047 Intermediate Similarity NPD4618 Approved
0.7047 Intermediate Similarity NPD4622 Approved
0.7041 Intermediate Similarity NPD6797 Phase 2
0.7039 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7266 Discontinued
0.7039 Intermediate Similarity NPD2346 Discontinued
0.7037 Intermediate Similarity NPD3882 Suspended
0.7034 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6652 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD6671 Approved
0.7027 Intermediate Similarity NPD8032 Phase 2
0.7027 Intermediate Similarity NPD4062 Phase 3
0.7007 Intermediate Similarity NPD5283 Phase 1
0.7006 Intermediate Similarity NPD6273 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data